Diagnostic utility of neurofilament markers for MND is limited in restricted disease phenotype and for differentiation from compressive myeloradiculopathies.

Baumgartner, Daniel; Mazanec, Radim; Hanzalová, Jitka

Baumgartner, Daniel; Mazanec, Radim; Hanzalová, Jitka.

Afiliación

Baumgartner D; Neuromuscular Centre, Department of Neurology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic. daniel.baumgartner@fnmotol.cz.
Mazanec R; Neuromuscular Centre, Department of Neurology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic.
Hanzalová J; Department of Immunology, Charles University, 2nd Faculty of Medicine and University Hospital Motol, V Uvalu 84, 150 06, Prague, Czech Republic.

J Neurol ; 270(3): 1600-1614, 2023 Mar.

Article en En | MEDLINE | ID: mdl-36456758

Asunto(s)

Enfermedad de la Neurona Motora; Radiculopatía; Enfermedades de la Médula Espinal; Humanos; Estudios Retrospectivos; Filamentos Intermedios; Biomarcadores; Proteínas de Neurofilamentos; Enfermedad de la Neurona Motora/diagnóstico; Fenotipo

Palabras clave

Amyotrophic lateral sclerosis; Biomarker; Cerebrospinal fluid; Motor neuron disease; Neurofilament

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Radiculopatía / Enfermedades de la Médula Espinal / Enfermedad de la Neurona Motora Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: J Neurol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google